Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers

British Journal of Ophthalmology

Volumn 80, Issue 5, 1996, Pages 413-415

  Shiota, Hiroshi ^a   Nitta, Keiko ^a   Naito, Takeshi ^a   Mimura, Yasuo ^a   Maruyama, Tokumi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LOBUCAVIR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA ULCER; DRUG EFFICACY; DRUG SOLUBILITY; FEMALE; HERPES SIMPLEX KERATITIS; HUMAN; MALE; PRIORITY JOURNAL; TIME; TOPICAL DRUG ADMINISTRATION; ULCER HEALING;

EID: 0029996853     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.5.413     Document Type: Article

References (25)

1. Kaufman HE, Martola EL, Dohlman C. Use of 5-iodo-2′-deoxyuridine (IDU) in treatment of herpes simplex keratitis. Arch Ophthalmol 1962; 68: 235-9.
2. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxymethyl)guanine. Proc Natl Acad Sci USA 1977; 74: 5716-20.
3. Schaeffer HJ, Beauchamp L, de Miranda P, Elion GB, Bauer DJ, Collins P. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 1978; 272: 583-5.
4. Pavan-Langston D, Dohlman CH. A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Am J Ophthalmol 1972; 74: 81-8.
5. Wellings PC, Awdry PN, Bors FH, Jones BR. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol 1972; 73: 932-42.
6. Pavan-Langston D, Campbell R. Acyclic antimetabolite therapy of experimental herpes simplex keratids. Am J Ophthalmol 1978; 86: 618-23.
7. Collum LMT, Benedict-Smith A, Hillary IB. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol 1980; 64: 766-9.
8. Kitano S, Yamanishi M, Shudo M, Uchida Y, Kaneko M, Tanaka N, et al. A double-blind comparative study of acyclovir (ACV) and IDU ophthalmic ointment in the treatment of herpes simplex keratids [in Japanese]. Jpn Rev Clin Ophthalmol 1983; 77: 1273-80.
9. Shiota H, Ogawa T, Yamane S. Studies of acyclovir and ara-AMP against herpetic keratitis in rabbits. In: Sundmacher R, ed. Herpetic eye diseases. Munich: Bergmann JF, 1981: 315-8.
10. Poirier RH, Kingham JD, de Miranda P, Annel M. Intraocular antiviral penetration. Arch Ophthalmol 1982; 100: 1964-7.
11. Slusarchyk WA, Young MG, Bisacchi GS, Hockstein DR, Zahler R. Synthesis of SQ-33,054, a novel cyclobutane nucleoside with potent antiviral acdvity. Tetrahedron Lett 1989; 30: 6453-6.
12. Nishiyama Y, Yamamoto N, Yamada Y, Daikoku T, Ichikawa Y, Takahashi K. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro. J Antibiot 1989; 42: 1854-9.
13. Clement JJ, Kern ER. Cycloburyl compounds as antiviral agents. Transplant Proc 1991; 23 (suppl 3): 159-61.
14. Hayashi S, Norbeck DW, Rosenbrook W, Fine RL, Matsukura M, Plattner JJ, et al. Cyclobut-A and cyclobutG, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. Antimicrob Agents Chemother 1990; 34: 287-94.
15. Field AK, Tuomari AV, McGeever-Rubin B, Terry BJ, Mazina KE, Haffey ML, et al. (±)-(1α,2β,3α)-9-[2,3-Bis(hydroxymethyl) cyclobutyl]guanine [(±)-BHCG or SQ 33054]: a potent and selective inhibitor of herpesviruses. Antiviral Res 1990; 13: 41-52.
16. Bisacchi GS, Braitman A, Cianci CW, Clark JM, Field AK, Hagen ME, et al. Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues. J Med Chem 1991; 34: 1415-21.
17. Yamanaka G, Tuomari AV, Hagen M, McGeever-Rubin B, Terry B, Haffey M, et al. Selective activity and cellular pharmacology of (1R-1α,2β,3α)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells. Mol Pharmacol 1991; 40: 446-53.
18. Shiota H, Nitta K, Naito T, Maruyama T, Honjo M. Effect of carbocyclic oxetanocin G on herpetic keratitis [in Japanese]. Chemother 1992; 40: 841-2.
19. McGill J, Tormey P, Walker CB. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol 1981; 65: 610-3.
20. Wilhelmus KR, Coster DJ, Jones BR. Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. Am J Ophthalmol 1981; 91: 323-7.
21. Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, et al. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 293-6.
22. McLeish WM, Pflugfelder SC, Crouse C, Rabinowitz S, Miller D, Hill EL, et al. Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1990; 109: 93-5.
23. Sonkin PL, Baratz KH, Frothingham R, Cobo LM. Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty. Ophthalmology 1992; 99: 1805-8.
24. Mori Y, Inoue Y, Shimomura Y. Herpetic epithelial keratitis caused by acyclovir-resistant strain. Jpn J Ophthalmol 1994; 38: 407-10.
25. McGill J, Holt-Wilson AD, McKinnon JR, Williams HP, Jones BR. Some aspects of the clinical use of trifluorothymidine in the treatment of herpetic ulceration of the cornea. Trans Ophthalmol Soc UK 1974; 94: 342-53.